In 2001, she founded Ganymed Pharmaceuticals as its Chief Scientific Officer, going on to become its Chief Executive Officer in 2008.[1] Ganymed was later acquired as a subsidiary by Astellas Pharma in 2016 for €1.3 billion, including milestone payments. At the time, this was the largest biotech deal in Germany so far.[2][6][7][8][6]